Benign prostatic hyperplasia (BPH), benign prostatic enlargement (BPE) and lower urinary
tract symptoms (LUTS) belong to the most frequent diseases in ageing men. Beyond the 6th …

Objectives To present historical and contemporary hypotheses on the pathogenesis of
benign prostatic hyperplasia (BPH), and the potential implications for current medical …

Anoikis is a unique mode of apoptotic cell death that occurs consequentially to insufficient
cell-matrix interactions. Resistance to anoikis is a critical contributor to tumor invasion and …

Determination of the role of insulin-like growth factor (IGF) family components in
carcinogenesis of several human tumors is based on numerous epidemiological and pre …

Benign prostatic hyperplasia (BPH) is the most common benign proliferative disease among
aging men. Androgens play a key role in the development and growth of the male genital …

Benign prostatic hyperplasia (BPH) is a common male condition that impacts many men's
quality of life by generating lower urinary tract symptoms (LUTS). In recent years …

Gastric cancer (GC) development trends have identified multiple processes ranging from
inflammation to carcinogenesis, however, key pathogenic mechanisms remain unclear …

Benign prostatic hyperplasia (BPH) and associated lower urinary tract symptoms (LUTS) are
highly prevalent in older men and represent a substantial challenge to public health …

Myofibroblast buildup and prostatic fibrosis play a crucial role in the development of benign
prostatic hyperplasia (BPH). Treatments specifically targeting myofibroblasts could be a …

Benign prostatic hyperplasia (BPH) is a prevalent condition affecting the male urinary
system, with its molecular mechanisms of pathogenesis remaining unclear. Y-27632, a non …